Razi Distribution Company (DERAZI) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DERAZI
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/09/30 | To 1401/09/30 | To 1400/09/30 |
|---|---|---|---|---|---|---|
| Operating revenue | 151,823,409 | 88,652,112 | 97,555,844 | 80,331,829 | 59,563,897 | 42,648,416 |
| Cost of operating revenue | -131,861,899 | -77,067,567 | -87,335,099 | -71,056,212 | -52,810,748 | -37,702,610 |
| Gross profit (loss) | 19,961,510 | 11,584,545 | 10,220,745 | 9,275,617 | 6,753,149 | 4,945,806 |
| Selling, general and administrative expenses | -13,947,301 | -10,670,847 | -7,075,093 | -5,060,684 | -3,568,147 | -2,331,962 |
| Other expenses | -127,614 | -20,516 | -72,978 | -100,000 | -26,000 | 0 |
| Operating profit (loss) | 5,886,595 | 893,182 | 3,072,674 | 4,189,658 | 3,288,165 | 2,617,764 |
| Finance costs | -2,949,856 | -2,734,640 | -1,924,356 | -1,980,283 | -1,103,000 | -636,515 |
| Other non-operating income and expenses | -550,031 | 51,571 | -50,570 | 22,935 | -10,791 | 132,302 |
| Profit (loss) from continuing operations before tax | 2,386,708 | -1,789,887 | 1,097,748 | 2,232,310 | 2,174,374 | 2,113,551 |
| Current year tax | -550,854 | 0 | -253,942 | -544,207 | -512,820 | -500,481 |
| Net profit (loss) from continuing operations | 1,835,854 | -1,789,887 | 843,806 | 1,688,103 | 1,661,554 | 1,613,070 |
| Net profit (loss) | 1,835,854 | -1,789,887 | 843,806 | 1,688,103 | 1,661,554 | 1,613,070 |
| Basic earnings (loss) per share | 2,387 rials | -1,790 rials | 684 rials | 1,688 rials | 1,662 rials | 0 rials |
| Net earnings (loss) per share, rials | 1,836 rials | -1,789 rials | 844 rials | 1,689 rials | 1,662 rials | 1,614 rials |
| Capital | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 |
Reporting periods
37 periods are on file for this report, from the period ending 1395/12/30 to the period ending 1405/06/31.